Ajooni Biotech Ltd.

AJOONINSEFast Moving Consumer GoodsAnimal FeedSmall Cap

₹3.77

▼ 1.57%

loading…

Composite

The company is a paramount manufacturer and supplier of superior quality of Patanjali Samvriddhi, Patanjali Garbhanjali, Patanjali Batisa-Pro etc. The products offered by them are processed using quality ingredients sourced from the trustworthy vendors of the market. Their range is appreciated for their features such as hygiene, accurate composition and easy to use. The offered range is processed under Quality certified manufacturing unit. Their manufactured veterinary products find use in the treatment and cure of many diseases in animals. Besides, they also undertake contracts for analytical method developments and stability studies. Available in air tight & hygienic packs, these medicines are highly appreciated for their accurate composition, precise pH value, effectiveness and longer shelf life.

www.ajoonibiotech.comSector: Fast Moving Consumer GoodsIndustry: Animal Feed

Q-DITS fundamental score

53Composite

Growth

Profitability

Valuation

Quality

Solvency

Earnings

Key metrics

MCap

₹65 Cr

TTM PE

15x

Industry PE

21x

TTM EPS

₹0.25

Book Value

₹5.29

Face Value

₹2

Div Yield

PEG

0.27x

1.1x

ROE

5.2%

ROCE

6.9%

EBITDA mgn

D/E

0.02

Int. Cover

14x

Curr. Ratio

12.86x

EPS

₹0.2

Growth — CAGR across horizons

Metric	1Y	3Y	5Y	10Y
Net Sales	59%	34.8%	29%	—
EBITDA	69.6%	31.3%	30.6%	—
Net Profit	28.2%	56.6%	63.3%	—

Score snapshot

Piotroski

5/9

Altman Z

1.87

Quality

50.2

Growth

66.7

Valuation

Earn. Qual

PEAD

SURGE

Loading price data…

Loading delivery data…

Revenue, profitability & returns

Revenue & Net Profit (₹ Cr)

RevenueNet Profit

Margins (%)

EBITDA%PAT%

Return ratios (%)

ROEROCEROA

Annual financials — last 10 years

Tap a row to expand the full chart

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
›RevenueCr	13	29	42	40	40	51	74	74	80	115
›EBITDACr	0	1	1	1	1	2	3	3	4	6
›EBITDA margin	1.8%	2.5%	2.7%	2.6%	3.3%	3.3%	4%	4.1%	5.5%	5%
›Net profitCr	0	0	0	0	0	0	1	1	2	3
›PAT margin	0.7%	1%	0.9%	1%	0.9%	0.7%	1.4%	1.5%	2.7%	2.9%
›EPS₹	₹0.27	₹0.55	₹0.12	₹0.12	₹0.07	₹0.07	₹0.21	₹0.13	₹0.25	₹0.2
›Revenue growth	83.5%	115.7%	48.5%	-6.3%	0.8%	27.5%	45.1%	0.6%	7.6%	43.2%
›PAT growth	32.6%	185.8%	40%	6.4%	-15.6%	7.6%	181.1%	7.2%	92.2%	56%
›ROE	20.4%	37%	6.8%	3.7%	2.5%	2.4%	6.6%	3.9%	5.1%	5.2%
›ROCE	18.6%	36.2%	10%	3.8%	4.4%	5.1%	9.1%	6%	7.7%	6.9%
›ROA	4.8%	3.6%	2.4%	2.2%	1.7%	1.5%	3.7%	2.6%	4.1%	4.8%
›P/E	0x	0x	7.8x	4.7x	2.9x	14.4x	10x	27.1x	21.1x	28.6x
›P/B	0x	0x	1.4x	0.8x	0.3x	1.5x	3.2x	0.7x	1.1x	1.1x
›D/E	1.5	0.6	0.5	0.4	0.3	0.4	0.3	0.1	0.1	0
›Current ratio	1.3x	0.7x	1.9x	6.1x	3x	2x	2.2x	2.3x	10.7x	12.9x
›Interest cover	7.9x	3.8x	2.4x	4.6x	2.5x	1.9x	3.7x	4.3x	6.4x	14x

Quarterly results

Tap a row to expand the full chart

Metric	2023-12	2024-03	2024-06	2024-09	2024-12	2025-03	2025-06	2025-09	2025-12	2026-03
›RevenueCr	20	20	26	26	34	29	31	32	59	59
›Rev growth YoY	88.6%	-52.5%	22.2%	32.1%	69.8%	49.5%	21.9%	23.4%	72.6%	100.7%
›EBITDACr	-1	2	1	1	1	1	1	2	3	3
›EBITDA margin	-3.3%	8.1%	3.7%	3%	2.7%	3.5%	2.3%	4.7%	5.2%	5.2%
›Net profitCr	0	1	0	1	1	2	1	1	2	2
›PAT growth YoY	307.4%	70.1%	16.1%	51.6%	66.1%	68.7%	66.9%	51.8%	125.4%	6.7%
›EPS₹	₹0.05	₹0.1	₹0.03	₹0.04	₹0.04	₹0.09	₹0.05	₹0.05	₹0.1	₹0.1

Balance sheet — last 10 years (₹ Cr)

Tap a row to expand the full chart

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
›Shareholders' equityCr	1	11	12	16	16	16	42	43	88	91
›ReservesCr	1	5	6	7	6	6	24	25	54	57
›Total borrowingsCr	0	0	0	0	0	0	0	0	0	0
›InvestmentsCr	6	7	5	3	1	1	17	4	21	0
›Total assetsCr	5	13	16	17	18	19	44	45	90	120
›Current assetsCr	6	11	12	18	21	22	35	32	62	42
›Current liabilitiesCr	8	6	2	6	10	10	15	3	5	27
›Trade payablesCr	5	1	1	2	5	7	10	2	4	9
›Gross blockCr	1	2	2	3	5	9	10	15	17	26

Cash flow statement (₹ Cr)

Tap a row to expand the full chart

Metric	2019	2020	2021	2022	2023	2024	2025	2026
›Operating CF (CFO)Cr	-5	-4	1	4	-6	23	-18	-6
›Investing CF (CFI)Cr	1	0	-3	-2	-16	8	-17	-16
›Financing CF (CFF)Cr	-1	3	2	-2	22	-4	25	15
›Net cash changeCr	-5	-1	0	-0	0	27	-10	-6
›Closing cashCr	1	0	0	0	0	27	-10	0

Cash flow components

CFO · CFI · CFF (₹ Cr)

CFOCFICFF

Q-DITS scorecard

Composite score

Quality (25%)50.2

Growth (25%)66.7

Valuation (20%)56

Piotroski (15%)56

Earnings Quality (10%)0

Momentum (5%)—

Weighted blend, rescaled to the components available for this stock.

Piotroski F-Score

5/9

✓ROA positiveROA 4.75%

✗CFO positiveCFO ₹-5.73 Cr

✓ROA improving4.09% → 4.75%

✗CFO > PAT (low accruals)CFO -5.73 vs PAT 3.37

✓Leverage decreasedD/E 0.05 → 0.02

✓Liquidity improvedCR 10.74 → 12.86

✗No share dilutionEPS 0.25 → 0.2

✗Margin improvedEBITDA mgn 5.53% → 5.02%

✓Asset turnover upAsset TO 1.52 → 1.62

Altman Z-Scoregrey

1.87

0.12

0.471

0.039

0.758

0.953

>2.9 safe · 1.23–2.9 grey · <1.23 distress

Quality

50.2/100

ROE

5.2%

ROCE

6.9%

Margin

2.9%

Debt

Int. cover

14x

Growth

66.7/100

Revenue 3Y

34.8%

Profit 3Y

56.6%

EPS

-20.6%

Valuation

56/100

28.6x

1.1x

EV/EBITDA

15.9x

vs universe median: PE 25.6x · PB 2.81x · EV 13.41x

Earnings quality

0/100

CFO₹-6 Cr

PAT₹3 Cr

Accrual ratio0.076

CFO/PAT-1.7x

PEAD · SURGE

+2 / +2

Revenue SUE1.64

EPS SUE1.32

Latest quarter2026-03

Rev growth YoY100.7%

Shareholding pattern

Promoter26.9%

FII/FPI0%

DII0%

Public73.1%

Tap a row to expand the full chart

Metric	2024-03	2024-06	2024-09	2024-12	2025-03	2025-06	2025-09	2025-12	2026-03
›Promoter	26.4%	26.9%	26.9%	26.9%	26.9%	26.9%	26.9%	26.9%	26.9%
›FII / FPI	0%	0%	0.3%	0.2%	0%	0%	0%	0%	0%
›DII	0%	0%	0%	0%	0%	0%	0%	0%	0%
›Public / Retail	73.6%	73.1%	73.1%	73.1%	73.1%	73.1%	73.1%	73.1%	73.1%
›Promoter pledge	0%	0%	0%	0%	0%	0%	0%	0%	0%

Documents & filings

Loading documents…

Peer comparison

Company	MCap (Cr)	Revenue	PAT	PE	PB	ROE%	ROCE%	D/E
Avanti Feeds Ltd.	13,187	6,067	656	21.8x	4x	21.6	28.5	0
Godrej Agrovet Ltd.	11,063	10,233	405	23.4x	5.4x	16.5	18.4	0.54
Mukka Proteins Ltd.	728	1,449	55	14x	1.5x	11.5	11.8	1.02
KSE Ltd.	604	1,680	84	7.2x	1.7x	35	44.2	0.08
Prima Industries Ltd.	20	7	4	4.6x	1.7x	-4	0.5	0.15
Prima Agro Ltd.	8	10	-0	—	0.5x	-2.9	-1	0.44